Relief Therapeutics

Route de Ferney 106, 1202 GenÃ¨ve, Switzerland

Details:

Details about Relief Therapeutics

Relief Therapeutics is a Swiss biopharmaceutical company developing innovative treatments for rare diseases, including RLF 100â¢ for respiratory conditions like COVID-19 induced lung injury, and ACER 001 for Urea Cycle Disorders and Maple Syrup Urine Di...

[email protected]

Year Founded

2013

Employees:

Employees at Relief Therapeutics

Taneli Jouhikainen

Founder and CEO at Relief Therapeutics

Michelle Lock

Chief Executive Officer at Relief Therapeutics

David Mccullough

Vice President of Market Access at Relief Therapeutics

Tim Snyder

Group Chief Financial Officer at Relief Therapeutics

Kelli Powell

Rare Disease Specialist at Relief Therapeutics

Michel Dreano

Managing Partner at Relief Therapeutics